micro-community-banner
 
Profile Image
  • Saved
Personalized diets may rebalance hormones and reduce obesity-related health risks

Obesity disrupts endocrine health through insulin resistance, chronic inflammation, and altered adipokine signaling. This narrative review explores how different dietary patterns influence hormonal balance in men and women.

Highlights:

  • In men, obesity is linked to decreased testosterone, reduced thyroid function, possibly reflecting thyroid hormone resistance, and elevated cortisol
  • In women, it increases risks for PCOS, infertility, and androgen excess
  • Calorie restriction, low-carbohydrate diets, Mediterranean, and plant-based patterns show hormonal benefits
  • Hormonal effects of dietary changes are often sex-specific

What sets this study apart:

Unlike conventional reviews that focus on single nutrients, this synthesis examines whole dietary patterns and their interaction with sex-specific hormonal physiology. It emphasizes the importance of individualized nutrition plans based on reproductive and metabolic profiles, underscoring that one-size-fits-all approaches are inadequate for endocrine health.

Limitations:

As a narrative review, conclusions are drawn from existing literature rather than new clinical data. Long-term outcomes and sustainability of restrictive diets, such as ketogenic or very low-carbohydrate regimens, remain underexplored.

What role does gender play in how dietary choices influence endocrine health?

Profile Image
  • Saved
  • Saved
Obesity and leptin in breast cancer angiogenesis - PubMed

Obesity and leptin in breast cancer angiogenesis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39439572/

At the time of breast cancer diagnosis, most patients meet the diagnostic criteria to be classified as obese or overweight. This can significantly impact patient outcome: breast cancer patients with...

Obesity-linked hyperleptinemia promotes angiogenesis in breast cancer, fostering tumor growth and metastasis. This review highlights leptin’s role in the tumor microenvironment of obese patients.

Profile Image
  • Saved
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update - PubMed

Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40789597/

Pharmacotherapy in obesity facilitates clinically meaningful weight loss and important improvements in obesity-related health complications. Clinicians who treat people with obesity with or without obesity-related health complications should appropriately use...

Updated Canadian guidelines recommend long-term, individualized pharmacotherapy alongside lifestyle therapy for obesity, with specific drug choices tailored to comorbidities and patient needs.

Profile Image
  • Saved
On the causes of obesity and its treatment: The end of the beginning - PubMed

On the causes of obesity and its treatment: The end of the beginning - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40043689/

Over the last 30 years, our understanding of the causes of obesity has been transformed, and new, highly effective medicines for reducing weight have been developed. This remarkable progress marks...

Obesity is now recognized as a biologic disorder with effective new therapies, including GLP-1 and other pathways. Future treatments promise tailored approaches addressing diverse pathogenic mechanisms and patient subgroups.

Profile Image